Pharmacia & Upjohn Detrol launch
Executive Summary
Worldwide sales of overactive bladder therapy tolterodine were $21 mil. in second quarter, firm reports. In the U.S., Detrol has "captured a market-leading share of new prescriptions among urologists after just eight weeks on the market," P&U says. The company has recently launched a direct-to-consumer ad campaign